Efficacy of HUMIRA in Subjects With Active Rheumatoid Arthritis

Abbott1,938 enrolled

Overview

The purpose of the study is to assess the efficacy of adalimumab in subjects with rheumatoid arthritis focusing on subject-reported outcomes and early response to treatment

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

1,938

Conditions

Rheumatoid Arthritis

Interventions

adalimumabDRUG

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Subject was age 18 or older and in good health (Investigator discretion) with a recent stable medical history. * Subject, based on assessment of investigator, meets the definition of active RA Exclusion Criteria: * Subject considered by the investigator, for any reason, to be an unsuitable candidate for the study * Female subject who is pregnant or breast-feeding or considering becoming pregnant

Locations (1)

Global Medical Information - Abbott

North Chicago, Illinois, United States

Outcomes

Primary Outcomes

Patient reported outcomes, clinical response indicators.

Secondary Outcomes

Subject reported assessments of disease activity, physician reported assessments of disease activity, safety parameters, clinical response indicators.

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.